A citation-based method for searching scientific literature

Mark W Sims, James Winter, Sean Brennan, Robert I Norman, G André Ng, Iain B Squire, Richard D Rainbow. Am J Physiol Heart Circ Physiol 2014
Times Cited: 9







List of co-cited articles
27 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



PKCepsilon inhibits the hyperglycemia-induced apoptosis signal in adult rat ventricular myocytes.
Ashwani Malhotra, Barinder P S Kang, Sayed Hashmi, Leonard G Meggs. Mol Cell Biochem 2005
21
22





Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes.
Yukitaka Shizukuda, Mary E Reyland, Peter M Buttrick. Am J Physiol Heart Circ Physiol 2002
68
22

Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat.
Antonio Ceriello, Lisa Quagliaro, Michele D'Amico, Clara Di Filippo, Raffaele Marfella, Francesco Nappo, Liberato Berrino, Francesco Rossi, Dario Giugliano. Diabetes 2002
229
22

Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans.
Joshua A Beckman, Allison B Goldfine, Mary Beth Gordon, Leslie A Garrett, Mark A Creager. Circ Res 2002
219
22

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.
H Ishii, M R Jirousek, D Koya, C Takagi, P Xia, A Clermont, S E Bursell, T S Kern, L M Ballas, W F Heath,[...]. Science 1996
908
22


Detrimental effects of acute hyperglycaemia on the rat heart.
R F Mapanga, D Joseph, B Symington, K-L Garson, C Kimar, R Kelly-Laubscher, M Faadiel Essop. Acta Physiol (Oxf) 2014
20
22

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.
A Bierhaus, S Schiekofer, M Schwaninger, M Andrassy, P M Humpert, J Chen, M Hong, T Luther, T Henle, I Klöting,[...]. Diabetes 2001
647
22

Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.
Yoshito Zamami, Shingo Takatori, Kousuke Yamawaki, Satoko Miyashita, Mitsunobu Mio, Yoshihisa Kitamura, Hiromu Kawasaki. Hypertens Res 2008
24
22

Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose.
Robert Jackson, Sean Brennan, Peter Fielding, Mark W Sims, R A John Challiss, David Adlam, Iain B Squire, Richard D Rainbow. Br J Pharmacol 2016
15
22



Acute hyperglycaemia disturbs cardiac repolarization in Type 1 diabetes.
D Gordin, C Forsblom, M Rönnback, P-H Groop. Diabet Med 2008
32
22

Endothelin-I and angiotensin II inhibit arterial voltage-gated K+ channels through different protein kinase C isoenzymes.
Richard D Rainbow, Robert I Norman, Diane E Everitt, Jennifer L Brignell, Noel W Davies, Nicholas B Standen. Cardiovasc Res 2009
38
22

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk.
Mikhail Kosiborod, Silvio E Inzucchi, Harlan M Krumholz, Lan Xiao, Philip G Jones, Suzanne Fiske, Frederick A Masoudi, Steven P Marso, John A Spertus. Circulation 2008
282
22

Regulation of intracerebral arteriolar tone by K(v) channels: effects of glucose and PKC.
Stephen V Straub, Helene Girouard, Paul E Doetsch, Rachael M Hannah, M Keith Wilkerson, Mark T Nelson. Am J Physiol Cell Physiol 2009
33
22

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.
Abhinav Goyal, Kenneth W Mahaffey, Jyotsna Garg, Jose C Nicolau, Judith S Hochman, W Douglas Weaver, Pierre Theroux, Gustavo B F Oliveira, Thomas G Todaro, Christopher F Mojcik,[...]. Eur Heart J 2006
141
22

Early opening of sarcolemmal ATP-sensitive potassium channels is not a key step in PKC-mediated cardioprotection.
Sean Brennan, Robert Jackson, Manish Patel, Mark W Sims, Diane Hudman, Robert I Norman, David Lodwick, Richard D Rainbow. J Mol Cell Cardiol 2015
6
33

Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.
Yanan Liu, Jiqin Jin, Shigang Qiao, Shaoqing Lei, Songyan Liao, Zhi-Dong Ge, Haobo Li, Gordon Tin-Chun Wong, Michael G Irwin, Zhengyuan Xia. Clin Sci (Lond) 2015
30
22

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes.
Mikhail Kosiborod, Saif S Rathore, Silvio E Inzucchi, Frederick A Masoudi, Yongfei Wang, Edward P Havranek, Harlan M Krumholz. Circulation 2005
433
22

Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.
Ann-Marie Svensson, Darren K McGuire, Putte Abrahamsson, Mikael Dellborg. Eur Heart J 2005
217
22

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
Prakash Deedwania, Mikhail Kosiborod, Eugene Barrett, Antonio Ceriello, William Isley, Theodore Mazzone, Philip Raskin. Circulation 2008
306
22

Nesfatin-1 activates cardiac vagal neurons of nucleus ambiguus and elicits bradycardia in conscious rats.
G Cristina Brailoiu, Elena Deliu, Andrei A Tica, Joseph E Rabinowitz, Douglas G Tilley, Khalid Benamar, Walter J Koch, Eugen Brailoiu. J Neurochem 2013
29
11


Nesfatin-1, a unique regulatory neuropeptide of the brain.
Artur Pałasz, Marek Krzystanek, John Worthington, Beata Czajkowska, Karol Kostro, Ryszard Wiaderkiewicz, Grzegorz Bajor. Neuropeptides 2012
68
11


Human protein NEFA, a novel DNA binding/EF-hand/leucine zipper protein. Molecular cloning and sequence analysis of the cDNA, isolation and characterization of the protein.
S Barnikol-Watanabe, N A Gross, H Götz, T Henkel, A Karabinos, H Kratzin, H U Barnikol, N Hilschmann. Biol Chem Hoppe Seyler 1994
80
11


Nesfatin-1 crosses the blood-brain barrier without saturation.
Weihong Pan, Hung Hsuchou, Abba J Kastin. Peptides 2007
148
11

Nesfatin-1: an overview and future clinical application.
Hiroyuki Shimizu, Sinsuke Oh-I, Shuichi Okada, Masatomo Mori. Endocr J 2009
78
11

Localization of nesfatin-1 neurons in the mouse brain and functional implication.
Miriam Goebel-Stengel, Lixin Wang, Andreas Stengel, Yvette Taché. Brain Res 2011
99
11

The role of natriuretic peptides in cardioprotection.
Toshio Nishikimi, Nobuyo Maeda, Hiroaki Matsuoka. Cardiovasc Res 2006
327
11

Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury.
T Angelone, E Filice, T Pasqua, N Amodio, M Galluccio, G Montesanti, A M Quintieri, M C Cerra. Cell Mol Life Sci 2013
72
11

Nesfatin-1 influences the excitability of neurons in the nucleus of the solitary tract and regulates cardiovascular function.
Andrea Mimee, Pauline M Smith, Alastair V Ferguson. Am J Physiol Regul Integr Comp Physiol 2012
48
11

The novel function of nesfatin-1: anti-hyperglycemia.
Yijing Su, Jing Zhang, Yanchun Tang, Feng Bi, Jian-Ning Liu. Biochem Biophys Res Commun 2010
122
11

Endocrine orchestration of cardiovascular, gastrointestinal and hypothalamic control.
T Angelone, A M Quintieri, N Amodio, M C Cerra. Curr Med Chem 2011
5
20

Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.
Alexander T Akhmedov, Vitalyi Rybin, José Marín-García. Heart Fail Rev 2015
70
11

Roles of obese-insulin resistance and anti-diabetic drugs on the heart with ischemia-reperfusion injury.
Nattayaporn Apaijai, Siriporn C Chattipakorn, Nipon Chattipakorn. Cardiovasc Drugs Ther 2014
9
11

Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1.
Tulin O Price, Willis K Samson, Michael L Niehoff, William A Banks. Peptides 2007
119
11


Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
Gonzalo Bustos, Jorge Abarca, Jorge Campusano, Victor Bustos, Viviana Noriega, Esteban Aliaga. Brain Res Brain Res Rev 2004
56
11

Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain.
G Cristina Brailoiu, Siok L Dun, Eugen Brailoiu, Saadet Inan, Jun Yang, Jaw Kang Chang, Nae J Dun. Endocrinology 2007
233
11

Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway.
Yuko Maejima, Udval Sedbazar, Shigetomo Suyama, Daisuke Kohno, Tatsushi Onaka, Eisuke Takano, Natsu Yoshida, Masato Koike, Yasuo Uchiyama, Ken Fujiwara,[...]. Cell Metab 2009
249
11

Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity.
Manjunath Ramanjaneya, Jing Chen, James E Brown, Gyanendra Tripathi, Manfred Hallschmid, Suketu Patel, Werner Kern, Edward W Hillhouse, Hendrik Lehnert, Bee K Tan,[...]. Endocrinology 2010
218
11

Cellular distribution, regulated expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis.
D García-Galiano, R Pineda, T Ilhan, J M Castellano, F Ruiz-Pino, M A Sánchez-Garrido, M J Vazquez, S Sangiao-Alvarellos, A Romero-Ruiz, L Pinilla,[...]. Endocrinology 2012
80
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.